Showing results (91-100 of 719) with videos related to

Sort By:
Pageof 72
PET Clinics|March 1, 2023
Neuroendocrine Neoplasms: Genetics and EpigeneticsJim Smith, Edward Barnett, Euan J Rodger, et al.
Biomedicines|April 30, 2021
177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate CancerYasemin Sanli, Duygu Has Simsek, Oner Sanli, et al.
Radiology|August 30, 2005
Deep venous thrombosis: withholding anticoagulation therapy after negative complete lower limb US findingsRathan M Subramaniam, Rebekah Heath, Tina Chou, et al.
Clinical Nuclear Medicine|June 30, 2016
18F-FDG PET/CT and Melanoma: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient ManagementEsther Mena, Mehdi Taghipour, Sara Sheikhbahaei, et al.
AJR. American Journal of Roentgenology|March 6, 2019
Timing and Impact of Posttreatment PET/CT After First 6 Months on Patient Management and Outcomes in Oropharyngeal Squamous Cell CarcinomaHelena You, Yin Xi, William Moore, et al.
Clinical Nuclear Medicine|August 29, 2018
Impact of DAT-SPECT on Management of Patients Suspected of ParkinsonismSahar Mirpour, Evrim B Turkbey, Wael Marashdeh, et al.
AJR. American Journal of Roentgenology|May 1, 2019
Therapy With 177Lu-DOTATATE: Clinical Implementation and Impact on Care of Patients With Neuroendocrine TumorsA Tuba Kendi, Thorvardur R Halfdanarson, Annie Packard, et al.
Emergency Medicine Australasia : EMA|November 7, 2006
Does an immunochromatographic D-dimer exclude acute lower limb deep venous thrombosis?Rathan M Subramaniam, Rebekah Heath, Kim Cox, et al.
Academic Radiology|November 9, 2013
Radiology research and medical studentsPat W Whitworth, Ankit Agarwal, Andrew Colucci, et al.
AJR. American Journal of Roentgenology|January 24, 2015
Two-time-point FDG PET/CT: liver SULmean repeatabilityAbdel K Tahari, Vasavi Paidpally, Alin Chirindel, et al.
Pageof 72